There needs to be new people contributing here. Too much of the old politics and GK agenda that permeate the conversations. Perhaps it will happen only once the company kick off the clinical trials. Until then we will have to endure the same rubbish by the same people. "Bring back GK"... "Sack the Board"... "You don't know anything"...